The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Open accessAbstract
BACKGROUND: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates on cancer occurrence and trends in the United States. METHODS: Incidence data were obtained from the CDC‐funded and NCI‐funded population‐based cancer registry programs and compiled by NAACCR. Data on cancer deaths were obtained from the National Center for Health Statistics National Vital Statistics System. Trends in age‐standardized incidence and death rates for all cancers combined and for the leading cancer types by sex, race, and ethnicity were estimated by joinpoint analysis and expressed as the annual percent change. Stage distribution and 5‐year survival by stage at diagnosis were calculated for breast cancer, colon and rectum (colorectal) cancer, lung and bronchus cancer, and melanoma of the skin. RESULTS: Overall cancer incidence rates from 2008 to 2014 decreased by 2.2% per year among men but were stable among women. Overall cancer death rates from 1999 to 2015 decreased by 1.8% per year among men and by 1.4% per year among women. Among men, incidence rates during the most recent 5‐year period (2010‐2014) decreased for 7 of the 17 most common cancer types, and death rates (2011‐2015) decreased for 11 of the 18 most common types. Among women, incidence rates declined for 7 of the 18 most common cancers, and death rates declined for 14 of the 20 most common cancers. Death rates decreased for cancer sites, including lung and bronchus (men and women), colorectal (men and women), female breast, and prostate. Death rates increased for cancers of the liver (men and women); pancreas (men and women); brain and other nervous system (men and women); oral cavity and pharynx (men only); soft tissue, including heart (men only); nonmelanoma skin (men only); and uterus. Incidence and death rates were higher among men than among women for all racial and ethnic groups. For all cancer sites combined, black men and white women had the highest incidence rates compared with other racial groups, and black men and black women had the highest death rates compared with other racial groups. Non‐Hispanic men and women had higher incidence and mortality rates than those of Hispanic ethnicity. Five‐year survival for cases diagnosed from 2007 through 2013 ranged from 100% (stage I) to 26.5% (stage IV) for female breast cancer, from 88.1% (stage I) to 12.6% (stage IV) for colorectal cancer, from 55.1% (stage I) to 4.2% (stage IV) for lung and bronchus cancer, and from 99.5% (stage I) to 16% (stage IV) for melanoma of the skin. Among children, overall cancer incidence rates increased by 0.8% per year from 2010 to 2014, and overall cancer death rates decreased by 1.5% per year from 2011 to 2015. CONCLUSIONS: For all cancer sites combined, cancer incidence rates decreased among men but were stable among women. Overall, there continue to be significant declines in cancer death rates among both men and women. Differences in rates and trends by race and ethnic group remain. Progress in reducing cancer mortality has not occurred for all sites. Examining stage distribution and 5‐year survival by stage highlights the potential benefits associated with early detection and treatment. Cancer 2018;124:2785‐2800. © 2018 American Cancer Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,774
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Self-citationHuman Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
General, U. S. S. (2014) · PsycEXTRA Dataset · doi:10.1037/e510072014-001 · Cited by 3,324
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Self-citationSiegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Self-citationBade, B. C., & Dela Cruz, C. S. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.10.001 · Cited by 1,911
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Annual report to the nation on the status of cancer, part I: National cancer statistics
Henley, S. J., Ward, E. M., Scott, S., Ma, J., Anderson, R. N., Firth, A. U., Thomas, C. C., Islami, F., Weir, H. K., Lewis, D. R., et al. (2020) · Cancer · doi:10.1002/cncr.32802 · Cited by 853
Self-citationMakker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Ovarian damage from chemotherapy and current approaches to its protection
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V, De Felici, M., Anderson, R. A., & Klinger, F. G. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz027 · Cited by 657
Self-citationPharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Tang, S.-M., Deng, X.-T., Zhou, J., Li, Q.-P., Ge, X.-X., & Miao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109604 · Cited by 654
Medical Care Costs Associated with Cancer Survivorship in the United States
Mariotto, A. B., Enewold, L., Zhao, J., Zeruto, C. A., & Yabroff, K. R. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1534 · Cited by 634
Fiorentini, D., Cappadone, C., Farruggia, G., & Prata, C. (2021) · Nutrients · doi:10.3390/nu13041136 · Cited by 559
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Islami, F., Ward, E. M., Sung, H., Cronin, K. A., Tangka, F. K. L., Sherman, R. L., Zhao, J., Anderson, R. N., Henley, S. J., Yabroff, K. R., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab131 · Cited by 478
Self-citationGyőrffy, B. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100625 · Cited by 464
Cancer Statistics for Hispanics/Latinos, 2018
Miller, K. D., Goding Sauer, A., Ortiz, A. P., Fedewa, S. A., Pinheiro, P. S., Tortolero‐Luna, G., Martinez‐Tyson, D., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21494 · Cited by 452
Self-citationMachine learning approaches to drug response prediction: challenges and recent progress
Adam, G., Rampášek, L., Safikhani, Z., Smirnov, P., Haibe-Kains, B., & Goldenberg, A. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0122-1 · Cited by 425
Projected estimates of cancer in Canada in 2020
Brenner, D. R., Weir, H. K., Demers, A. A., Ellison, L. F., Louzado, C., Shaw, A., Turner, D., Woods, R. R., & Smith, L. M. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.191292 · Cited by 375
Epidemiology and risk-stratification of NAFLD-associated HCC
Ioannou, G. N. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.012 · Cited by 361
Progress in cancer mortality, incidence, and survival: a global overview
Santucci, C., Carioli, G., Bertuccio, P., Malvezzi, M., Pastorino, U., Boffetta, P., Negri, E., Bosetti, C., & La Vecchia, C. (2020) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000594 · Cited by 339
Ward, E. M., Sherman, R. L., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B. A., Scott, S., Ma, J., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 323
Self-citationGong, Z., & Dai, Z. (2021) · Advanced Science · doi:10.1002/advs.202002178 · Cited by 320
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
Dasari, S., Njiki, S., Mbemi, A., Yedjou, C. G., & Tchounwou, P. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031532 · Cited by 308
Analysis of status and countermeasures of cancer incidence and mortality in China
Wu, C., Li, M., Meng, H., Liu, Y., Niu, W., Zhou, Y., Zhao, R., Duan, Y., Zeng, Z., Li, X., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9461-5 · Cited by 299
Automatic multiorgan segmentation in thorax CT images using U‐net‐ GAN
Dong, X., Lei, Y., Wang, T., Thomas, M., Tang, L., Curran, W. J., Liu, T., & Yang, X. (2019) · Medical Physics · doi:10.1002/mp.13458 · Cited by 275
Colon Cancer: A Clinician’s Perspective in 2019
Ahmed, M. (2020) · Gastroenterology Research · doi:10.14740/gr1239 · Cited by 275
Immunotherapy for hepatocellular carcinoma
Zongyi, Y., & Xiaowu, L. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.002 · Cited by 265
Coleman, R., Finkelstein, D. M., Barrios, C., Martin, M., Iwata, H., Hegg, R., Glaspy, J., Periañez, A. M., Tonkin, K., Deleu, I., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30687-4 · Cited by 261
Risk Factors for the Diagnosis of Colorectal Cancer
Lewandowska, A., Rudzki, G., Lewandowski, T., Stryjkowska-Góra, A., & Rudzki, S. (2022) · Cancer Control · doi:10.1177/10732748211056692 · Cited by 254
Alfano, C. M., Leach, C. R., Smith, T. G., Miller, K. D., Alcaraz, K. I., Cannady, R. S., Wender, R. C., & Brawley, O. W. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21548 · Cited by 179
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Fogelson, K. A., Dorrestein, P. C., Zarrinpar, A., & Knight, R. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.022 · Cited by 177
LeBoeuf, S. E., Wu, W. L., Karakousi, T. R., Karadal, B., Jackson, S. R., Davidson, S. M., Wong, K.-K., Koralov, S. B., Sayin, V. I., & Papagiannakopoulos, T. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.012 · Cited by 150
Jin, E. H., Lee, D., Bae, J. H., Kang, H. Y., Kwak, M.-S., Seo, J. Y., Yang, J. I., Yang, S. Y., Lim, S. H., Yim, J. Y., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.036 · Cited by 140
AGA technical review on gastric intestinal metaplasia-epidemiology and risk factors
Altayar, O., Davitkov, P., Shah, S. C., Gawron, A. J., Morgan, D. R., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.002 · Cited by 135
Liu, X., Zhang, Z., Song, Y., Xie, H., & Dong, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1065263 · Cited by 102
The characteristics of informal cancer caregivers in the United States
Kent, E. E., Mollica, M. A., Buckenmaier, S., & Wilder Smith, A. (2019) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2019.06.002 · Cited by 89
Yu, D., Liu, Z., Su, C., Han, Y., Duan, X., Zhang, R., Liu, X., Yang, Y., & Xu, S. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13204 · Cited by 80
Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression
Xue, J., Cao, Z., Cheng, Y., Wang, J., Liu, Y., Yang, R., Li, H., Jiang, W., Li, G., Zhao, W., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.043 · Cited by 72
Interethnic differences in pancreatic cancer incidence and risk factors: The Multiethnic Cohort
Huang, B. Z., Stram, D. O., Le Marchand, L., Haiman, C. A., Wilkens, L. R., Pandol, S. J., Zhang, Z., Monroe, K. R., & Setiawan, V. W. (2019) · Cancer Medicine · doi:10.1002/cam4.2209 · Cited by 52
Personality traits and preventive cancer screenings in the health retirement study
Aschwanden, D., Gerend, M. A., Luchetti, M., Stephan, Y., Sutin, A. R., & Terracciano, A. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105763 · Cited by 42
Colorectal Cancer Immunotherapy: State of the Art and Future Directions
Cornista, A. M., Giolito, M. V., Baker, K., Hazime, H., Dufait, I., Datta, J., Khumukcham, S. S., De Ridder, M., Roper, J., Abreu, M. T., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.007 · Cited by 39
Colorectal Cancer Screening in a Changing World
Bresalier, R. S. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.05.002 · Cited by 29
Wakefield, D. V., Carnell, M., Dove, A. P. H., Edmonston, D. Y., Garner, W. B., Hubler, A., Makepeace, L., Hanson, R., Ozdenerol, E., Chun, S. G., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.03.016 · Cited by 26
Soares, P. V., Kannen, V., Jordão Junior, A. A., & Garcia, S. B. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2018.1506489 · Cited by 19
Liu, L., Zhang, J., Deapen, D., Stern, M. C., Sipin, A., Pandol, S. J., & Setiawan, V. W. (2019) · Pancreas · doi:10.1097/mpa.0000000000001337 · Cited by 18
Case Discrimination: Self-supervised Feature Learning for the Classification of Focal Liver Lesions
Dong, H., Iwamoto, Y., Han, X., Lin, L., Hu, H., Cai, X., & Chen, Y.-W. (2021) · Smart Innovation, Systems and Technologies · doi:10.1007/978-981-16-3013-2_20 · Cited by 12
Response to Lehrer and Rheinstein
Fedewa, S. A., Ma, J., & Jemal, A. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa093 · Cited by 5
Self-citation
Metadata
- Authors
- Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., Kohler, B. A., & Jemal, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2018-05-22
- Volume
- 124
- Issue
- 13
- Pages
- 2785-2800
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2803358834
- Cited by
- 1,485
- References
- 89
- FWCI
- 77.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.